First 10 runs free
    Intelligence Feed event · Capital · 2026-11-07

    Oracle completes $20B capital raise via $10B equity and $10B bond issuance

    Question

    Oracle completes $20B capital raise via $10B equity and $10B bond issuance

    Direct answer

    Oracle finalized a $20 billion multi-tranche funding round in five trading days, split evenly between equity and debt. The equity issuance of $10 billion priced at $116 per share, introducing roughly 3% dilution to existing equity holders. The parallel $10 billion debt placement underscores the capital intensity required to build out sovereign and enterprise AI cloud capacity. The substantial capital draw tests market absorption capacity for technology corporate credit and large-cap equity issuance.

    Original publisher
    Market Ontology
    Evidence through
    2026-11-07
    Published
    2026-11-07
    Revision
    1 · 2026-11-08

    Cite as: Market Ontology, “Oracle completes $20B capital raise via $10B equity and $10B bond issuance”, revision 1, evidence through 2026-11-07. https://marketontology.com/market-events/2026-11-07/oracle-completes-20b-capital-raise-via-10b-equity-and-10b-bond-issuance-3c2288

    CAPITAL
    Oracle completes $20B capital raise via $10B equity and $10B bond issuance
    Oracle finalized a $20 billion multi-tranche funding round in five trading days, split evenly between equity and debt. The equity issuance of $10 billion priced at $116 per share, introducing roughly 3% dilution to existing equity holders. The parallel $10 billion debt placement underscores the capital intensity required to build out sovereign and enterprise AI cloud capacity. The substantial capital draw tests market absorption capacity for technology corporate credit and large-cap equity issuance.
    ORCL
    Impact
    73
    YESTERDAY
    SIG
    85%
    ORCL
    Oracle completes $20B capital raise via $10B equity and $10B bond issuance
    Oracle finalized a $20 billion multi-tranche funding round in five trading days, split evenly between equity and debt. The equity issuance of $10 billion priced at $116 per share, introducing roughly 3% dilution to existing equity holders. The parallel $10 billion debt placement underscores the capital intensity required to build out sovereign and enterprise AI cloud capacity. The substantial capital draw tests market absorption capacity for technology corporate credit and large-cap equity issuance.
    → Large-scale primary equity and debt supply absorbs secondary software liquidity and establishes a reference yield floor for hyperscale corporate credit.
    Impact
    Oracle finalized a $20 billion multi-tranche funding round in five trading days, split evenly between equity and debt. The equity issuance of $10 billion priced at $116 per share, introducing roughly 3% dilution to existing equity holders. The parallel $10 billion debt placement underscores the capital intensity required to build out sovereign and enterprise AI cloud capacity. The substantial capital draw tests market absorption capacity for technology corporate credit and large-cap equity issuance.
    Affected
    ORCL
    Transmission
    Large-scale primary equity and debt supply absorbs secondary software liquidity and establishes a reference yield floor for hyperscale corporate credit.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    ORCLequity dilution absorption at $116 price levelMixed1-5dOracle sold $10 billion of stock at $116 a share, adding ~3% dilution, alongside $10B in bonds.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    ORCLMixed126.19 2026-11-03PendingPendingPending

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    Find trades for this development

    Screen tradable expressions of this catalyst against your horizon and constraints. Nothing is submitted without your review.

    First 10 runs free

    First 10 runs free

    See today's live cards

    Public pages are published 24 hours after the product shows them. The product shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open live cards